Catalyst Pharma announces a $4.5 mln registered direct common stock offering (CPRX) 4.05 : Co announces that it has entered into definitive agreements with institutional investors to sell 1,488,332 shares of its common stock at a price of $3.00 per share in a registered direct common stock offering.